SCHEMBL1000077

SCHEMBL1000077

Brc1ccc(-c2cncnc2)s1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SNCA P37840 1/20 0.46
MAPT P10636 3/20 0.44
HSD17B10 Q99714 2/20 0.44
ALOX12 P18054 2/20 0.44
MEN1 O00255 1/20 0.44
ALOX15 P16050 1/20 0.44
KMT2A Q03164 1/20 0.44
ATM Q13315 1/20 0.38
RAB9A P51151 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
NPC1 O15118 2/20 0.38
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 2/20 0.38
TP53 P04637 1/20 0.38
HPGD P15428 1/20 0.38
PPARG P37231 1/20 0.38
NCOA2 Q15596 1/20 0.38
NCOA1 Q15788 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25165536 0.81 ATM (0.44) ATMCYP2A6CYP3A4CYP2D6CYP2C9
SCHEMBL12402387 0.79 CYP2A6 (0.61) MAPTHSD17B10ALOX15SMN1; SMN2KDM4E
SCHEMBL2778388 0.76 SNCA (0.61) SNCAMAPTHSD17B10ALOX12MEN1
SCHEMBL9101993 0.76 HDAC3 (0.52) SNCAMAPTHSD17B10ALOX12MEN1
SCHEMBL12951370 0.76 MAPT (0.39) MAPTHSD17B10MEN1ALOX15KMT2A
SCHEMBL4340111 0.74 SNCA (0.59) SNCAMAPTHSD17B10ALOX12MEN1
SCHEMBL197157 0.72 SNCA (0.50) SNCAMAPTHSD17B10ALOX12MEN1
SCHEMBL3425584 0.71 MAPT (0.47) SNCAMAPTHSD17B10ALOX12MEN1
SCHEMBL5889177 0.70 SNCA (0.48) SNCAMAPTHSD17B10ALOX12MEN1
SCHEMBL498474 0.70 SNCA (0.48) SNCAMAPTHSD17B10ALOX12MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7867980-B2 Lincosamide derivatives and antimicrobial agents comprising the same as active ingredient MEIJI SEIKA KAISHA, LTD. (JP) 2011-01-11 US disclosed
US-20100184746-A1 LINCOSAMIDE DERIVATIVES AND ANTIMICROBIAL AGENTS COMPRISING THE SAME AS ACTIVE INGREDIENT MEIJI SEIKA KAISHA LTD 2010-07-22 US disclosed
EP-2166015-A1 LINCOSAMIDE DERIVATIVE, AND ANTIBACTERIAL AGENT COMPRISING THE SAME AS ACTIVE INGREDIENT Meiji Seika Kaisha Ltd. (JP) 2010-03-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100184746-A1 LINCOSAMIDE DERIVATIVES AND ANTIMICROBIAL AGENTS COMPRISING THE SAME AS ACTIVE INGREDIENT SIRT6, LAS1L, MRPS18A SNCA 3726/4885MAPT 2807/4885HSD17B10 1687/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.